SEGAL LLOYD MITCHELL (President and CEO) sold 8.7% of their position (7.95K shares) of REPARE THERAPEUTICS INC. on the open market
Open‑market sale worth $37.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/27/2024ACC: 0001415889-24-009249
Officer· President and CEO
Since Jun 2020
-7.95K
Net shares
Net seller
$37.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.95K disposed
Non-Derivative Transactions3
Common Shares
Indirect
Shares
−2.65K
Price / share
$4.79
Trade value
$12.69K
% of position
2.9%
3/25/2024
91.82K→89.17K
Common Shares
Indirect
Shares
−2.65K
Price / share
$4.64
Trade value
$12.30K
% of position
3.0%
3/26/2024
89.17K→86.52K
Common Shares
Indirect
Shares
−2.65K
Price / share
$4.63
Trade value
$12.27K
% of position
3.1%
3/27/2024
86.52K→83.87K
Total
Net shares
−7.95K
Net value
-$37.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 3/25/2024 | S · Sale | −2.65K | $4.79 | $12.69K | 2.9% | 91.82K | 89.17K |
| Common Shares Indirect | 3/26/2024 | S · Sale | −2.65K | $4.64 | $12.30K | 3.0% | 89.17K | 86.52K |
| Common Shares Indirect | 3/27/2024 | S · Sale | −2.65K | $4.63 | $12.27K | 3.1% | 86.52K | 83.87K |
| Total | −7.95K | -$37.26K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
DirectShares owned124.68K
Total
124.68K direct124.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 124.68K | Direct |
| Total | 124.68K | 124.68K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported